Incidence, clinical features and impact on anti-tuberculosis treatment of anti-tuberculosis drug induced liver injury (ATLI) in China.

<h4>Background</h4>Anti-tuberculosis drug induced liver injury (ATLI) is emerging as a significant threat to tuberculosis control in China, though limited data is available about the burden of ATLI at population level. This study aimed to estimate the incidence of ATLI, to better underst...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Penghui Shang, Yinyin Xia, Feiying Liu, Xiaomeng Wang, Yanli Yuan, Daiyu Hu, Dehua Tu, Yixin Chen, Peiyuan Deng, Shiming Cheng, Lin Zhou, Yu Ma, Lizhen Zhu, Weiwei Gao, Hongyuan Wang, Dafang Chen, Li Yang, Pingping He, Shanshan Wu, Shaowen Tang, Xiaozhen Lv, Zheng Shu, Yuan Zhang, Zhirong Yang, Yan Chen, Na Li, Feng Sun, Xiaoting Li, Yingjian He, Paul Garner, Siyan Zhan
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2011
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/83a444dda8f54a5ebff90cae7b14de65
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Incidence, clinical features and impact on anti-tuberculosis treatment of anti-tuberculosis drug induced liver injury (ATLI) in China.

Ejemplares similares